Anavex Life Sciences Corp (AVXL)

[Reyeton]

Why don’t we see if we can break them and get it all for next to nothing? What do we have to lose? We have the agreement in place if it doesn’t work out, in the mean time we put the screws to them and see what shakes out. It’s just money right? No honor among thieves.

I-think-you-nailed-it.--It-has-always-been-my-opinion-BIIB-is-not-and-never-has-been-trustworthy-partnership-material.

Elan-found-itself-in-a-vulnerable-position-with-Antigren-(Tysabri),-needing-more-material-to-complete-clinical-trial.--BIIB-was-happy-to-help-for-a-50%-partnership.--Where-is-Elan-today?

Idec-was-allowed-to-gain-a-51%-stake-in-BIIB-so-BIIB-could-take-over-Idec's-partnership-with-Genentech-for-Rituxan.--Idec's-usefullness-to-BIIB-quickly-evaporated.--Where-is-Idec-today?


© 2017 Genentech USA, Inc., and Biogen. All Rights Reserved.
Jointly Marketed by: Biogen and Genentech USA, Inc.
Rituxan® is a registered trademark of Biogen.